BACKGROUND: The HIV epidemic among black men who have sex with men (BMSM) demands urgent public health attention. Pre-exposure prophylaxis (PrEP) is a highly efficacious option for preventing HIV, but characteristics of PrEP use among community samples of BMSM are not well-understood. METHODS: A serial cross-sectional survey assessment (N = 4184 BMSM reporting HIV-negative/unsure status) and HIV testing were conducted at Black Gay Pride events in 6 US cities in 2014, 2015, 2016, and 2017. RESULTS: HIV prevalence was higher among BMSM self-reporting current PrEP use (1 of 3 participants) than BMSM not self-reporting current PrEP use (1 of 5 participants) [32.3%, N = 103/319 vs. 20.0%, N = 639/3,193, adjusted odds ratio (aOR) = 1.68, 95% confidence interval (CI): 1.31 to 2.15]. BMSM reporting current PrEP use (N = 380) were more likely to report having a greater number of male sex partners (aOR = 1.02, 95% CI: 1.01 to 1.03), a sexually transmitted infection diagnosis (aOR = 2.44, 95% CI: 1.88 to 3.16), and stimulant drug use (aOR = 2.05, 95% CI, 1.21 to 3.47) when compared with BMSM not reporting current PrEP use (N = 3804). PrEP use increased from 4.7% (2014) to 15.5% (2017) (aOR = 1.19, 95% CI: 1.13 to 1.25). Among PrEP users, inability to afford health care coverage was associated with testing HIV-positive (aOR = 2.10, 95% CI: 1.24 to 3.56). CONCLUSIONS: The high prevalence of HIV infection among BMSM reporting PrEP use is concerning. It does not, however, challenge the efficacy of PrEP itself but rather the uptake of the surrounding preventative package including behavioral risk reduction support, sexually transmitted infection treatment, and medication adherence counseling. Further research to understand barriers to fully effective PrEP is needed to guide operational and behavioral interventions that close the gap on incident infection.
BACKGROUND: The HIV epidemic among black men who have sex with men (BMSM) demands urgent public health attention. Pre-exposure prophylaxis (PrEP) is a highly efficacious option for preventing HIV, but characteristics of PrEP use among community samples of BMSM are not well-understood. METHODS: A serial cross-sectional survey assessment (N = 4184 BMSM reporting HIV-negative/unsure status) and HIV testing were conducted at Black Gay Pride events in 6 US cities in 2014, 2015, 2016, and 2017. RESULTS: HIV prevalence was higher among BMSM self-reporting current PrEP use (1 of 3 participants) than BMSM not self-reporting current PrEP use (1 of 5 participants) [32.3%, N = 103/319 vs. 20.0%, N = 639/3,193, adjusted odds ratio (aOR) = 1.68, 95% confidence interval (CI): 1.31 to 2.15]. BMSM reporting current PrEP use (N = 380) were more likely to report having a greater number of male sex partners (aOR = 1.02, 95% CI: 1.01 to 1.03), a sexually transmitted infection diagnosis (aOR = 2.44, 95% CI: 1.88 to 3.16), and stimulant drug use (aOR = 2.05, 95% CI, 1.21 to 3.47) when compared with BMSM not reporting current PrEP use (N = 3804). PrEP use increased from 4.7% (2014) to 15.5% (2017) (aOR = 1.19, 95% CI: 1.13 to 1.25). Among PrEP users, inability to afford health care coverage was associated with testing HIV-positive (aOR = 2.10, 95% CI: 1.24 to 3.56). CONCLUSIONS: The high prevalence of HIV infection among BMSM reporting PrEP use is concerning. It does not, however, challenge the efficacy of PrEP itself but rather the uptake of the surrounding preventative package including behavioral risk reduction support, sexually transmitted infection treatment, and medication adherence counseling. Further research to understand barriers to fully effective PrEP is needed to guide operational and behavioral interventions that close the gap on incident infection.
Authors: Matthew J Mimiaga; Sari L Reisner; Yves-Michel Fontaine; Sean E Bland; Maura A Driscoll; Deborah Isenberg; Kevin Cranston; Margie R Skeer; Kenneth H Mayer Journal: Drug Alcohol Depend Date: 2010-03-23 Impact factor: 4.492
Authors: Robert M Grant; Peter L Anderson; Vanessa McMahan; Albert Liu; K Rivet Amico; Megha Mehrotra; Sybil Hosek; Carlos Mosquera; Martin Casapia; Orlando Montoya; Susan Buchbinder; Valdilea G Veloso; Kenneth Mayer; Suwat Chariyalertsak; Linda-Gail Bekker; Esper G Kallas; Mauro Schechter; Juan Guanira; Lane Bushman; David N Burns; James F Rooney; David V Glidden Journal: Lancet Infect Dis Date: 2014-07-22 Impact factor: 25.071
Authors: Charles H Hinkin; Terry R Barclay; Steven A Castellon; Andrew J Levine; Ramani S Durvasula; Sarah D Marion; Hector F Myers; Douglas Longshore Journal: AIDS Behav Date: 2007-03
Authors: Katherine R Turner; Willi McFarland; Timothy A Kellogg; Ernest Wong; Kimberly Page-Shafer; Brain Louie; Jim Dilley; Charlotte K Kent; Jeffrey Klausner Journal: Sex Transm Dis Date: 2003-04 Impact factor: 2.830
Authors: Charles H Hinkin; David J Hardy; Karen I Mason; Steven A Castellon; Ramani S Durvasula; Mona N Lam; Marta Stefaniak Journal: AIDS Date: 2004-01-01 Impact factor: 4.177
Authors: Morgan M Philbin; Caroline M Parker; Richard G Parker; Patrick A Wilson; Jonathan Garcia; Jennifer S Hirsch Journal: AIDS Patient Care STDS Date: 2016-05-24 Impact factor: 5.078
Authors: Samuel M Jenness; Akshay Sharma; Steven M Goodreau; Eli S Rosenberg; Kevin M Weiss; Karen W Hoover; Dawn K Smith; Patrick Sullivan Journal: PLoS One Date: 2017-01-06 Impact factor: 3.240
Authors: Antoine Chaillon; Martin Hoenigl; Sanjay R Mehta; Nadir Weibel; Susan J Little; Davey M Smith Journal: Sci Rep Date: 2016-06-24 Impact factor: 4.379
Authors: Cristian J Chandler; Leigh A Bukowski; Derrick D Matthews; Mary E Hawk; Nina Markovic; Ronald D Stall; James E Egan Journal: AIDS Care Date: 2019-08-28
Authors: Cheryl Hendrickson; Lawrence Long; David van de Vijver; Charles Boucher; Heidi O'Bra; Cassidy W Claassen; Mwansa Njelesani; Crispin Moyo; Daliso B Mumba; Hasina Subedar; Lloyd Mulenga; Sydney Rosen; Brooke E Nichols Journal: Lancet HIV Date: 2020-01-31 Impact factor: 12.767
Authors: Leigh A Bukowski; Melvin C Hampton; Cesar G Escobar-Viera; Jordan M Sang; Cristian J Chandler; Emmett Henderson; Stephanie L Creasy; Ronald D Stall Journal: J Urban Health Date: 2019-10 Impact factor: 3.671
Authors: Derrick D Matthews; Jordan M Sang; Cristian J Chandler; Leigh A Bukowski; M Reuel Friedman; Lisa A Eaton; Ron D Stall Journal: Prev Sci Date: 2019-10
Authors: Wilson Vincent; John L Peterson; Erik D Storholm; David M Huebner; Torsten B Neilands; Sarah K Calabrese; Gregory M Rebchook; Judy Y Tan; Lance Pollack; Susan M Kegeles Journal: AIDS Behav Date: 2019-10
Authors: Darren L Whitfield; Geetha Beauchamp; Sheldon Fields; LaRon Nelson; Manya Magnus; Jagadīśa-Devaśrī Dācus; Jonathan Paul; Peter Anderson; Darrell Wheeler Journal: AIDS Care Date: 2020-08-24